无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜

中文名稱  磷酸化酪氨酸激酶受體A抗體規(guī)格 

英文名稱  Anti-Phospho-TrkA (Tyr791)

別    名 TrkA (Phospho-Tyr791); TrkA (Phospho Tyr791); TrkA (Phospho-Y791); p-TrkA(Tyr791); CIPA; CIPA; DKFZp781I14186; gp140trk; High affinity nerve growth factor receptor; High affinity nerve growth factor receptor precursor; High affinity nerve growth factor receptor precursor; MTC; MTC; neurotrophic tyrosine kinase receptor type 1; neurotrophic tyrosine kinase receptor type 1; Ntrk 1; Ntrk1; Ntrk1; NTRK1_HUMAN; Oncogene TRK; Oncogene TRK; p140 TrkA; p140-TrkA; TRK 1; Trk A; TRK; TRK; Trk-A; TRK1; TRK1 transforming tyrosine kinase protein; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor A; Tyrosine kinase receptor; Tyrosine Receptor Kinase A.

產品屬性：

磷酸化酪氨酸激酶受體A抗體規(guī)格 濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應   Human, Mouse, Rat

產品類型   一抗 磷酸化抗體  

研究領域    細胞生物 免疫學 神經生物學 信號轉導 轉錄調節(jié)因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 90kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human TrkA around the phosphorylation site of Tyr791

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

磷酸化酪氨酸激酶受體A抗體規(guī)格 產品應用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蠟切片需做抗原修復） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產品介紹 The Trk family of nerve growth factor receptors includes Trk A(also referfed to as Trk A gp140),Trk B and Trk C. The prototype member of this gene family, Trk A, encodes a 140 kDa cell surface receptor , gp140, the expression of which is restricted in vivo to neurons of the sensory spinal and cranial gangliaof neurocrest origin. Nerve growth factor (NGF) stimulates tyrosine phosphorylation of Trk gp 140 in neural cell lines and in embryonic dorsal root ganglia. By comparison, BDNF and to a lesser extent, NT-3, but not NGF, can induce tyrosine phophorylayion of Trk B gp 145. The third member of the Trk receptor family, Trk C incodes a 140 kDa protein, Trk C gp140, that is preferentially expressed in brain tissue and primarily functions as a receptor for NT-3.An additional component of the Trk receptor complex, NGFR p175, binds to neurotrophic factors with low affinity but is required for efficient signaling. NGFR p175 accelerates Trk activation and may recruit downstream dffector molecules to the ligand-bound receptor complex.

Function : Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand, it can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors.

Isoform TrkA-III is resistant to NGF, constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed.

Subunit : Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Homodimerization is induced by binding of a NGF dimer. Interacts with SQSTM1; bridges NTRK1 to NGFR. Forms a ternary complex with NGFR and KIDINS220; this complex is affected by the expression levels of KIDINS220 and an increase in KIDINS220 expression leads to a decreased association of NGFR and NTRK1 (By similarity). Interacts with SH2D1A; regulates NTRK1 (By similarity). Interacts (phosphorylated upon activation by NGF) with SHC1; mediates SHC1 phosphorylation and activation. Interacts (phosphorylated upon activation by NGF) with PLCG1; mediates PLCG1 phosphorylation and activation. Interacts (phosphorylated) with SH2B1 and SH2B2. Interacts with GRB2. Interacts with PIK3R1. Interacts with FRS2. Interacts with SORT1; may regulate NTRK1 anterograde axonal transport. Interacts with RAB7A.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Early endosome membrane; Single-pass type I membrane protein. Note=Internalized to endosomes upon binding of NGF or NTF3 and further transported to the cell body via a retrograde axonal transport.

Tissue Specificity : Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors.

Post-translational modifications : Ligand-mediated autophosphorylation. Interaction with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at Tyr-496 mediates interaction and phosphorylation of SHC1.

N-glycosylated (Probable). Isoform TrkA-I is N-glycosylated.

Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor (By similarity)

DISEASE : Defects in NTRK1 are a cause of congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]. CIPA is characterized by a congenital insensitivity to pain, anhidrosis (absence of sweating), absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation. This rare autosomal recessive disorder is also known as congenital sensory neuropathy with anhidrosis or hereditary sensory and autonomic neuropathy type IV or familial dysautonomia type II.

Defects in NTRK1 are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=Chromosomal aberrations involving NTRK1 are found in thyroid papillary carcinomas. Translocation t(1;3)(q21;q11) with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to the 3'-end of NTRK1; a rearrangement with TPM3 generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1; an intrachromosomal rearrangement that links the protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the C-terminus of the NTRK1 protein.

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.

Contains 2 Ig-like C2-type (immunoglobulin-like) domains.

Contains 2 LRR (leucine-rich) repeats.

Contains 1 LRRCT domain.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P04629.4

TrkA是NGF的功能性受體，當其與NGF結合后，可激活酪氨酸激酶信號傳遞系統(tǒng)，從而啟動，產生生物效應。

實驗流程：

全、新、優(yōu)、品、好四大特點：

磷酸化酪氨酸激酶受體A抗體規(guī)格 全：公司提供上萬種產品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產品在我司都能找到。

新：產品更新速度較快，基本上每周都有新產品出現(xiàn)。

優(yōu)：產品質量好，投訴比較少。

好：我公司具有優(yōu)質的技術團隊，產品一旦售出，實驗過程中遇到困難可提供在線技術咨詢。使您使用產品時沒有任何的后顧之憂。

技術外包服務:

★磷酸化酪氨酸激酶受體A抗體規(guī)格 分子生物學：質粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構建、細胞RNAi技術等等。

正在熱銷的相關產品：

Anti-H1N1-A/HRP(Influenza A virus)California 辣根過氧化物酶標記兔抗季節(jié)性A型人病毒H1N1抗體IgG(美國加州型)Multi-class antibodies規(guī)格： 0.2ml

MT-II(Melanotan II Acetate) 醋酸美拉諾坦IIMulti-class antibodies規(guī)格： 1g

CD14/內毒素受體抗體 Anti-CD14 0.1ml

SYVN1 英文名稱： 滑膜細胞凋亡抑制物1抗體 0.1ml

EphA7 英文名稱： 酪酸蛋白激酶受體A7抗體 0.2ml

Rhesus antibody Rh phospho-HDAC1(Ser423+Ser421) 磷酸化組蛋白去乙?；?抗體 規(guī)格 0.1ml

MT-II(Melanotan II Acetate) 醋酸美拉諾坦IIMulti-class antibodies規(guī)格： 1g

Anti-P-p38 ERK/MAPK14 /FITC 熒光素標記磷酸化-原活化蛋白激酶p38抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Mouse Anti-human IgG Monoclonal Antibody/HRP 辣根過氧化物酶標記小鼠抗人IgG單克隆抗體Multi-class antibodies規(guī)格： 0.1ml

致癌基因抗體 Anti-C-Myc/MYC/MTLC 0.1ml

Mouse Anti-Rabbit IgM/Alexa Fluor 488 Alexa Fluor 488標記的小鼠抗兔IgM 0.1ml

Phospho-FOXO1 + FOXO3 + FOXO4 (phospho T24 + T32) 英文名稱： 磷酸化叉頭蛋白家族抗體 0.1ml

Rhesus antibody Rh PILR beta 細胞表面受體PILRβ抗體 規(guī)格 0.2ml

Mouse Anti-human IgG Monoclonal Antibody/HRP 辣根過氧化物酶標記小鼠抗人IgG單克隆抗體Multi-class antibodies規(guī)格： 0.1ml

P311 protein 相關蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-CD54/ICAM-1 細胞間粘附分子-1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh P38 MAPK(Phospho-Thr180/Tyr182) 磷酸化-原活化蛋白激酶p38抗體(P-p38 MAPK) 規(guī)格 0.1ml

IL1B Kit Human 人 IL-1 beta / IL1B / IL-1F2 ELISA配對抗體 ELISA

TUB 1 英文名稱： TUB蛋白抗體 0.2ml

COBL 英文名稱： -綜合征相關COBL蛋白抗體 0.1ml

Anti-CD54/ICAM-1 細胞間粘附分子-1抗體Multi-class antibodies規(guī)格： 0.1ml

FASLG Protein Human 重組人 Fas Ligand / FASLG / CD95L 蛋白 (His 標簽)

CNE-2 低分化細胞

ICOS Others Mouse 小鼠 ICOS / AILIM / CD278 人細胞裂解液 (陽性對照)

BxPC-3人原位*腺癌細胞 BxPC-3 in situ pancreatic adenocarcinoma cells 1640+10% FBS

小鼠細胞(分泌促生長激素分泌激素);AtT-20

人成纖維細胞( HCF) ( 5×105 ) GC-1, 鼠精原細胞 Mouse

CL-0456TM4(正常小鼠Sertoli細胞)5×106cells/瓶×2

SIGIRR Others Human 人 SIGIRR / TIR8 人細胞裂解液 (陽性對照)

人膀胱基質成纖維細胞RNAHBdSF miRNA5 μg

T24細胞，人膀胱移行細胞癌細胞 大鼠細胞(wistar 大鼠),CBRH7919細胞 RN-c, 大鼠皮質神經元

Ishikawa(人細胞) 5×106cells/瓶×2

hPC-PL-c 人類胎盤周細胞(hPC-PL) 500,000cells 小鼠巨噬細胞MMa

磷酸化酪氨酸激酶受體A抗體規(guī)格 FASLG Protein Human 重組人 Fas Ligand / FASLG / CD95L 蛋白 (His 標簽)

CNE-2 低分化細胞

ICOS Others Mouse 小鼠 ICOS / AILIM / CD278 人細胞裂解液 (陽性對照)

BxPC-3人原位*腺癌細胞 BxPC-3 in situ pancreatic adenocarcinoma cells 1640+10% FBS

小鼠細胞(分泌促生長激素分泌激素);AtT-20

人成纖維細胞( HCF) ( 5×105 ) GC-1, 鼠精原細胞 Mouse